ChartRow logo
Data provided bySource: Twelve Data
PeersCAHCORMCKSPYQQQNVDA
Share this page

HSIC — Henry Schein price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in HSIC be worth today? →
HSIC returns: By year · By month · By week · Trailing

Price data

Price
$86.22
YTD price return
+14.08%
YTD total return
+14.08%
Market cap
9.5B
Enterprise value
13.9B
Shares outstanding
110.5M
52W low
$68.70
52W high
$92.18
From 52W high
-6.47%
From 52W low
+25.50%
52W range
75%$68.70–$92.18
Beta
0.80

Volume

Rel volume
1.42×
30D volume
1.5M
30D $ vol
131.3M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
none
Insider net 1Y
−$7.9M

Form 4 transactions by trade date, as filed; latest on file 2026-05-11.

Fundamentals

Sales (ttm)
13.7B
Sales/share
$124.25
EPS (ttm)
$3.65
FCF (ttm)
559M
FCF/share
$5.06
Book value/share
$28.58
Net margin
3.07%
ROE
13.33%
ROA
3.66%
Debt / equity
0.75×
Current ratio
1.33

Growth (CAGR, ttm) · 10Y

Sales
+6.17%+2.67%+2.34%+1.97%
Net income
+7.70%-1.84%-7.65%-1.66%
FCF
+38.87%-4.87%-5.01%-0.24%
Shares
-6.12%-5.26%-4.43%-3.69%

Per-share growth (CAGR, ttm) · 10Y

EPS
+15.38%+2.95%-3.67%+1.93%
Sales/share
+13.10%+8.38%+7.08%+5.87%
FCF/share
+47.93%+0.42%-0.61%+3.51%
Book value/share
+0.10%+0.57%+2.76%+4.74%
Price
+17.58%+8.50%+1.70%+3.45%
Total return
+17.58%+8.50%+1.70%+3.45%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
23.6×
P/OI (ttm)
13.4×
Fwd P/E
14.3×
P/S (ttm)
0.7×
P/B (mrq)
3.0×
P/FCF (ttm)
17.0×
EV/EBITDA (fy)
13.3×
EV/Sales (ttm)
1.0×
FCF yield (ttm)
5.87%
Buyback yield (realized, 1y)
6.12%
Shareholder yield (realized, 1y)
6.12%
Buyback yield (cash, ttm)
6.82%
Shareholder yield (cash, ttm)
6.82%

Vs own 10Y history

P/E
74th
P/OI
38th
P/S
17th
P/B
53rd
P/FCF
39th

Bar = where today’s multiple sits in HSIC’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-13#

Data provided bySource: Twelve Data
1D
+0.09%
5D
+0.20%
1M
+1.40%
3M
-4.33%
YTD
+14.08%
1Y
+17.56%
5Y
+8.79%
1D
+0.09%
5D
+0.20%
1M
+1.40%
3M
-4.33%
YTD
+14.08%
1Y
+17.56%
5Y
+8.79%

Fundamentals#

Revenue

5Y CAGR +5.4%10Y CAGR +2.2%YoY +4.0%
$13.7B TTM$3.5B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +4.1%10Y CAGR −1.2%YoY +17.7%
$709M TTM$193M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +3.0%10Y CAGR +1.4%YoY +26.2%
$3.65 TTM$1.06 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +0.8%10Y CAGR +0.5%YoY −7.1%
$559M TTM$131M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $687M, capex −$128M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $161M, capex −$30M

Shares (diluted)

5Y −15.1%10Y −27.7%YoY −7.0%
115.3M TTM112.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −0.3%10Y CAGR −1.8%YoY +17.8%
$421M TTM$119M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full HSIC financials →

Henry Schein, Inc. is a health care solutions company that serves office-based dental, medical, and veterinary professionals. Henry Schein provides a broad range of products and services through its core businesses in healthcare distribution, specialty products, and technology-enabled value-added services. Its offerings include consumable supplies, dental equipment, practice-management software, logistics support, and related clinical solutions that help practices manage daily operations more efficiently. The company also supports dental laboratories, government and institutional health care clinics, and other alternate care sites with products and services tailored to professional workflows. With a strong presence in dental and medical markets, Henry Schein plays an important role in the supply chain for outpatient health care providers and practice support services.

Melville, NY·25,000 employees·Medical Distribution·henryschein.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding HSIC#

28 of the 193 ETFs ChartRow carries live hold HSIC. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
RSPInvesco S&P 500 Equal Weight ETF0.2%
VBRVanguard Small-Cap Value ETF0.2%
XLVHealth Care Select Sector SPDR Fund0.1%
VHTVanguard Health Care ETF0.1%
VBVanguard Small-Cap ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
SPYVSPDR Portfolio S&P 500 Value ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+23.75%+1.14%
JNJJohnson & Johnson+14.94%+0.79%
ABBVAbbVie Inc.+7.53%+0.20%
UNHUnitedHealth Group Incorporated Common Stock (DE)+7.86%+0.58%
MRKMerck & Co. Inc.+4.07%+0.55%
NVSNovartis AG+12.70%+0.16%
TMOThermo Fisher Scientific Inc.+5.61%+0.11%
AMGNAmgen Inc.+12.80%-0.30%